Detection of soluble TRAIL in HBV infected patients and its clinical implications

World Journal of Gastroenterology

Volumn 8, Issue 6, 2002, Pages 1077-1080

  Han, Li Hui ^a   Sun, Wen Sheng ^a   Ma, Chun Hong ^a   Zhang, Li Ning ^a   Liu, Su Xia ^a   Zhang, Qiu ^a   Gao, Li Fen ^a   Chen, You Hai ^b  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOCHEMICAL MARKER; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; ARTICLE; BLOOD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B VIRUS; HOST; HUMAN; IMMUNITY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; VIRUS CARRIER;

EID: 0036899204     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i6.1077     Document Type: Article

References (22)

1. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA. Identification and characterization of new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673-682
2. Pan G, Ni J, Wei YF, Genztz R, Dixit VM. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997; 277: 815-818
3. Pan GJ, Ni G, Yu YF, Yu G, Gentz R, Dixit VM. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett 1998; 424: 41-45
4. Schneider P, Bodmer JL, Thome M, Hoffmann K, Holler N, Tschopp J. Characterization of two receptors for TRAIL. FEBS Lett 1997; 416: 329-334
5. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace AJ Jr, El-Deriy WS. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor α. Cancer Res 1998; 58: 1593-1598
6. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Schubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowiski P, Ashkenazi K. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997; 277: 818-821
7. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooler KA, Smith CA, Goodwin RJ, Rauch CT. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL. EMBO J 1997; 16: 5386-5397
8. Screaton GR, Mongkolsapaya J, Xu XN, Cowper AE, McMichael AJ, Bell JI. TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL. Curr Biol 1997; 7: 693-696
9. Dul E, Aperbaulm ER, Eichman C, DiPrinzio R, Dodds RA, James RE, Rosenberg M, Lee JC, Young PR. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 1998; 273: 14363-14367
10. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999; 5: 157-163
11. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999; 104: 155-162
12. Velthuis JH, Rouschop KM, De Bont HJ, Mulder GJ, Nagelkerke JF. Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis. J Biol Chem 2002; 277: 24631-24637
13. Knight MJ, Riffkin CD, Muscat AM, Ashley DM, Hawkins CJ. Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells. Oncogene 2001; 20: 5789-5798
14. Raftery MJ, Schwab M, Eibert SM, Samstag Y, Walczak H, Schonrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: A multilayered viral defense strategy. Immunity 2001; 15: 997-1009
15. Siegmund D, Mauri D, Peters N, Juo P, Thome M, Reichwein M, Blenis J, Scheurich P, Tschopp J, Wajant H. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway. J Biol Chem 2001; 276: 32585-32590
16. Ehrmann JJr, Galuszkova D, Ehrmann J, Krc I, Jezdinska V, Vojtesek B, Murray PG, Kolao Z. Apoptosis-related proteins, BCL-2, BAX, FAS, FAS-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infection. Pathol Oncol Res 2000; 6: 130-135
17. Hayashi N, Mita E. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J Viral Hepat 1999; 6: 357-365
18. Hayashi N, Mita E. Fas system and apoptosis in viral hepatitis. J Gastroenterol Hepatol 1997; 12: S223-226
19. Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996; 24: 1-7
20. Milich DR, Jones J, Hughes J, Maruyama T. Role of T cell tolerance in the persistence of hepatitis B virus infection. J Immunother 1993; 14: 226-233
21. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A 1990; 87: 6599-6603
22. Thomas HC, Jacyna M, Waters J, Main J. Virus-host interaction in chronic hepatitis B virus infection. Semin Liver Dis 1988; 8: 342-349